- Home
- / PMV Pharma
PMV Pharma
Stock Price
$1.6
2024-10-29
Market Capitalization
$85 M
2024-10-29
PMV Pharma Summary
Company Summary
- Overview
- PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with a pharmaceutical development focus.
- Type
- Public
- Status
- Active
- Founded
- 2013
- HQ
- Cranbury Township, NJ, US | view all locations
- Website
- http://www.pmvpharma.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Arnold Levine, Co-Founder & Member, Scientific Advisory Board
Binh Vu, Vice President, Drug Discovery and CMC
Robert Ticktin, General Counsel
PMV Pharma Financials
Summary Financials
- Net income (FY, 2024)
- ($58.7M)
- Cash (FY, 2024)
- $40.9M
- EBIT (FY, 2024)
- ($85.4M)
- Enterprise value
- $45.3M